AI Dominates Insurtech Funding in Q2 As Early-Stage Deals Cool Sharply
Quarterly insurtech funding reached $2.44 billion in the second quarter of 2026, the highest level since the second quarter of 2022, according to Gallagher Re’s Global Insurtech Report.
Deal count climbed to 107, matching a recent high last seen in the first quarter of 2024. Nearly all of that capital, 99.1%, went to AI-focused companies, comprising $2.42 billion across 95 deals, Gallagher Re found.
At the same time, early-stage insurtech funding fell 51.8% quarter over quarter, dropping from $548.50 million in the first quarter of 2026 to $264.19 million in the second quarter, even as early-stage deal count rose to 54, the most since the 64 early-stage deals recorded in the first quarter of 2024.
Mega-Rounds Drive The Funding Surge
The jump in overall funding was driven largely by $1.67 billion tied to deals of $100 million or more, the highest total for such mega-rounds since the fourth quarter of 2021, when $3.78 billion was raised across 13 deals, according to the report. The average insurtech deal size rose for a fourth consecutive quarter to $29.46 million.
P&C insurtechs led the increase, with funding more than doubling from $910 million in the first quarter of 2026 to $1.84 billion in the second quarter. Earth imagery startup ICEYE alone raised roughly a fifth of the quarter’s total funding through a $520 million Series F round. L&H funding moved in the opposite direction, slipping from $720 million to $600 million over the same period.
P&C deal count rose to 66 from 55, while L&H deals climbed to 41, the highest count since the third quarter of 2022. The report also noted that 12.1% of P&C insurtech deals went to “insurer-classified” insurtechs, the highest share since the fourth quarter of 2014, including two mega-round deals of $100 million or more to startup-focused insurer Corgi.
Despite the rebound in overall capital, Gallagher Re flagged a narrowing innovation pipeline. Funding averaged $1.65 billion per quarter across the final quarter of 2025 and first quarter of 2026, up from a long-run average of $1.1 billion per quarter over the preceding two and a half years.
Yet deal count in the first quarter of 2026 had fallen to just 81, the lowest since the second quarter of 2016, which saw 67 deals. The median insurtech deal size reached $10.0 million in the first quarter of 2026, nearly double the $5.3 million recorded at the height of 2021’s venture-funding boom, raising the question of whether capital is concentrating among fewer innovators.
Insurers Deepen Their Own AI Bets
(Re)insurance companies backed 27 tech investments in the second quarter of 2026, down from 32 in the first quarter, with 51.9% of those deals classified as early-stage, according to the report. MS&AD Group-linked investors led insurer dealmaking activity, with Mitsui Sumitomo Insurance Venture Capital backing seven companies and MS&AD Ventures backing three. Notable partnerships during the quarter, the report noted, included Ageas UK with Wrisk, Allianz Turkey with nettle, Chubb with Insify, Liberty Mutual with ICEYE, and Munich Re with Sixfold.
Gallagher Re also pointed to a broader shift as incumbent (re)insurers increasingly build their own AI tools rather than buying them from vendors, describing the “buy vs. build” debate as being at its healthiest point in a decade.
The report said the near-term risk for insurance incumbents lies in falling behind peers already equipping employees with AI tools and assistants, while startups built around thin AI workflow wrappers face growing platform risk as incumbents deploy enterprise AI platforms from providers such as Anthropic and OpenAI directly.
Gallagher Re noted that demand among (re)insurers has shifted from simple efficiency gains toward additional outputs such as data-driven insights, predictive pricing analysis and portfolio optimization, with those already holding data, client relationships, market expertise and access to capital best positioned to benefit.
Obtain the full report here. &

